Clinical Trial: A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Compensated Liver Cirrhosis
Study Type: INTERVENTIONAL
Official Title: Safety, Tolerability and Pharmacodynamics of BI 770371 Administered Intravenously in Patients With Compensated Cirrhosis Due to MASH: a Phase IIa, Multi-center, Randomized, Double-blind, Placebo-contr
Brief Summary:
This study is open to people with cirrhosis caused by a liver disease called MASH (metabolic dysfunction-associated steatohepatitis).The purpose of this study is to find out how well a medicine called BI 770371 is tolerated.Participants are put into 2 groups by chance.One group gets BI 770371 as an infusion into a vein and the other group gets placebo as an infusion into a vein.Placebo infusions look like BI 770371 infusions but do not contain any medicine.Participants get an infusion every 3 weeks for 12…
Read more